The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases

Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab

(2012) Lorenzo Dagna et al.   JOURNAL OF CLINICAL ONCOLOGY

CNS involvement and treatment with interferon-  are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

(2011) L. Arnaud et al.   BLOOD

Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients

(2011) L. Arnaud et al.   BLOOD

Erdheim-Chester Disease

(2011) Emanuel Della Torre et al.   CLINICAL NUCLEAR MEDICINE

Erdheim–Chester disease

(2011) Julien Haroche et al.   CURRENT OPINION IN RHEUMATOLOGY

Scintigraphic Diagnosis of Erdheim-Chester Disease

(2011) Hans Balink et al.   JOURNAL OF CLINICAL ONCOLOGY

Pulmonary involvement in Erdheim-Chester disease: A single-center study of thirty-four patients and a review of the literature

(2010) Laurent Arnaud et al.   ARTHRITIS AND RHEUMATISM

Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis

(2010) L. Dagna et al.   RHEUMATOLOGY

Cardiac Involvement in Erdheim-Chester Disease

(2009) Julien Haroche et al.   CIRCULATION

Retroperitoneal infiltration as the first sign of Erdheim-Chester disease

(2008) Pierre Colin et al.   INTERNATIONAL JOURNAL OF UROLOGY